Latest News about Nanocovax
Results of a clinical trial phase 2 of made-in-Vietnam Covid-19 vaccine Nanocovax showed that 100% of vaccinated people made antibodies to fight the virus. The vaccine was also effective on the British variant of the coronavirus.
Vietnam has completed the first-dose vaccination of 560 volunteers who participated in the Phase 2 trial of Nanocovax's Covid-19 vaccine,
While negotiating with foreign vaccine providers, Vietnam will accelerate vaccine purchases to ensure that all people have access to Covid-19 vaccines.
Vietnam has ordered 30 million doses of vaccine from the UK, with first doses are expected to arrive in the country in the first quarter this year to serve widespread vaccination.
Twenty volunteers received the second shots of Nanocovax - a Vietnam-developed COVID-19 vaccine at the Military Medical University on January 20.
Three volunteers getting the first shot of the 25mcg dose of Nanocovax, the first Vietnamese COVID-19 vaccine to be tested on humans, last December received the second on January 14.
icon SCI-TECH & ENVIRONMENT
The first human trial of COVID-19 vaccine Nanocovax began in Vietnam on December 17 with the first three volunteers, one man and two women aged 20-25, receiving injections at the Military Medical Academy.
icon Doanh nhân
Doanh nghiệp nghiên cứu và sản xuất vắc-xin Nanocovax sắp thử nghiệm lâm sàng của Việt Nam có vốn hơn 700 tỷ đồng, được định giá tới hơn 5.000 tỷ đồng do ông Hồ Nhân sáng lập.